Safety Assessment of Polyaminopropyl Biguanide (Polyhexamethylene Biguanide Hydrochloride) as Used in Cosmetics.


Journal

International journal of toxicology
ISSN: 1092-874X
Titre abrégé: Int J Toxicol
Pays: United States
ID NLM: 9708436

Informations de publication

Date de publication:
Historique:
entrez: 18 11 2020
pubmed: 19 11 2020
medline: 29 7 2021
Statut: ppublish

Résumé

The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of Polyaminopropyl Biguanide (polyhexamethylene biguanide hydrochloride), which functions as a preservative in cosmetic products. The Panel reviewed relevant data relating to the safety of this ingredient and concluded that Polyaminopropyl Biguanide is safe in cosmetics in the present practices of use and concentration described in the safety assessment, when formulated to be nonirritating and nonsensitizing, which may be based on a quantitative risk assessment or other accepted methodologies. The Panel also concluded that the data are insufficient to determine the safety of Polyaminopropyl Biguanide in products that may be incidentally inhaled.

Identifiants

pubmed: 33203268
doi: 10.1177/1091581820958683
doi:

Substances chimiques

Biguanides 0
Cosmetics 0
polyaminopropylbiguanide 0
polihexanide 322U039GMF

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

26S-73S

Auteurs

Wilbur Johnson (W)

* 44002Cosmetic Ingredient Review Senior Scientific Analyst/Writer.

Ivan Boyer (I)

** Former 44002Cosmetic Ingredient Review Toxicologist.

Jinqiu Zhu (J)

*** 44002Cosmetic Ingredient Review Toxicologist.

Wilma F Bergfeld (WF)

**** Expert Panel for Cosmetic Ingredient Safety Member.

Donald V Belsito (DV)

**** Expert Panel for Cosmetic Ingredient Safety Member.

Ronald A Hill (RA)

**** Expert Panel for Cosmetic Ingredient Safety Member.

Curtis D Klaassen (CD)

**** Expert Panel for Cosmetic Ingredient Safety Member.

Daniel C Liebler (DC)

**** Expert Panel for Cosmetic Ingredient Safety Member.

James G Marks (JG)

**** Expert Panel for Cosmetic Ingredient Safety Member.

Ronald C Shank (RC)

**** Expert Panel for Cosmetic Ingredient Safety Member.

Thomas J Slaga (TJ)

**** Expert Panel for Cosmetic Ingredient Safety Member.

Paul W Snyder (PW)

**** Expert Panel for Cosmetic Ingredient Safety Member.

Bart Heldreth (B)

† 44002Cosmetic Ingredient Review Executive Director.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH